ArticleWorld journal of nephrology2025
Temporal trends and disparities in stroke mortality among adults with chronic kidney disease in the United States, 1999-2020.
Article in World journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic kidney disease (CKD) is a major independent stroke risk factor. This study characterizes 22-year national trends and disparities in stroke mortality among United States adults with CKD.
aimTo evaluate 22-year national trends and demographic disparities in stroke mortality among United States adults with CKD to inform targeted strategies for reducing cerebrovascular risk in this vulnerable population.
methodsUsing Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research Multiple Cause-of-Death data (1999-2020), we analyzed stroke deaths (underlying cause) with CKD (contributing cause) among adults ≥ 25 years. Age-adjusted mortality rates per 100000 population were calculated. Joinpoint regression estimated annual percentage changes (APCs) and average APCs with 95% confidence intervals, stratified by sex, race/ethnicity, region, and urbanization.
resultsAmong 37308 stroke deaths with CKD, the overall age-adjusted stroke mortality rates (AAMR) declined from 1.08 (95%CI: 1.03-1.13) in 1999 to 0.71 (95%CI: 0.68-0.75) in 2020 (average annual percent change: -1.79%). Significant trends included a decline from 1999-2009 (APC: -4.25%), followed by an increase from 2009-2012 (APC: 23.25%), a sharp decline from 2012-2015 (APC: -28.10%), and another increase from 2015-2020 (APC: 8.72%). Males had higher mortality than females (AAMR 0.79
conclusionWhile stroke mortality among United States adults with CKD significantly declined over two decades, reflecting improvements in prevention and management, substantial disparities persist. The findings underscore the critical need for targeted public health interventions to address underlying biological, structural, and systemic determinants of cerebrovascular risk in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.